Weekly Summary: Advances in Weight Management, Healthy Living, and Eating - November 2025

1. Major Breakthrough in Weight Loss Drug Accessibility
The Trump administration announced a historic deal to significantly reduce the cost of GLP-1 weight loss medications such as Wegovy and Zepbound. Previously priced between $1,000 and $1,350 per month, these drugs will now cost about $350 per month through the TrumpRx program. Medicare coverage will introduce a $50 co-pay for eligible beneficiaries, with prices as low as $245 under Medicare plans. Oral formulations have been priced at $150 per month for starting doses. This deal is especially important given that approximately 40% of U.S. adults are classified as having obesity, highlighting a critical step toward improved weight management and chronic disease control.

2. Underutilization of Cardiac Rehabilitation Despite Proven Efficacy
Research published in November 2025 emphasizes that only 23% of eligible Americans under 65 enroll in cardiac rehabilitation after heart attack or cardiac procedures, with fewer than 10% completing the entire recommended program. Participation in cardiac rehab reduces hospital readmission rates by 42% in the 6 to 12 months following treatment. The mortality risk reduction observed mirrors the benefits seen with established medications such as statins and beta-blockers. Women appear to derive even greater mortality risk reduction from cardiac rehabilitation than men.

3. Comprehensive Assessment of GLP-1 Medication Benefits and Risks
In a large cohort study involving 2.4 million adults with type 2 diabetes, GLP-1 receptor agonists were associated with a 10-20% reduction in risks for dementia, Alzheimer's disease, substance use disorders, and seizure disorders. These medications demonstrated cardiovascular mortality reductions between 22% and 31%. However, an increased risk of pancreatitis and kidney issues was also identified, emphasizing the importance of careful monitoring despite the drugs’ overall favorable safety profile.

4. The Planetary Health Diet: A Global Opportunity to Save Lives and Environment
The 2025 EAT-Lancet Commission report identified that adopting a plant-forward diet featuring limited red meat (one serving weekly), moderate poultry and fish (two servings weekly), and 3–4 eggs per week could prevent approximately 15 million premature deaths annually worldwide, equating to 40,000 lives saved daily. The shift would also cut diet-related agricultural greenhouse gas emissions by 50%, thereby reducing the annual $15 trillion global costs attributed to health care and environmental damage from current food systems.

5. Exercise Dosage and Mortality: Evidence from a Large Longitudinal Study
A 30-year study following over 116,000 adults demonstrates that exceeding the minimum recommended 150 minutes of moderate or 75 minutes of vigorous physical activity per week leads to substantially lower mortality rates. Engaging in 300 to 600 minutes weekly was linked to 26-31% reduced all-cause mortality and 28-38% reduced cardiovascular mortality. Even meeting the minimum recommended activity levels yields a 22-31% reduction in cardiovascular disease mortality. Notably, long-term high-intensity exercise showed no evidence of harm, supporting physical activity as a key pillar of healthy living.

Sources

• https://abcnews.go.com/GMA/Wellness/video/trump-announces-major-deal-lower-cost-weight-loss-127330711
• https://www.heart.org/en/news/2025/11/11/many-people-miss-out-on-the-benefits-of-cardiac-rehab-heres-why-you-shouldnt
• https://medicine.washu.edu/news/study-identifies-benefits-risks-linked-to-popular-weight-loss-drugs/
• https://abcnews.go.com/US/landmark-study-recommends-planetary-health-diet-saving-lives/story?id=126137310
• https://www.ama-assn.org/public-health/prevention-wellness/massive-study-uncovers-how-much-exercise-needed-live-longer